Pilot study of index and safety of switching to Denosumab from Zoledronic acid for hepatocellular carcinoma with bone metastasis.
Not Applicable
- Conditions
- hepatocellular carcinoma with bone metastasis
- Registration Number
- JPRN-UMIN000009675
- Lead Sponsor
- Department of Gastroenterology and Metabolism,Hiroshima University Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 35
Inclusion Criteria
Not provided
Exclusion Criteria
1) CCr < 30 2) A pregnant woman, or a woman suspected of pregnancy. 10) Any condition that is unstable or could jeopardize the safety of the patient and its compliance in the study, in the investigator's judgment. 3) With odontogenic infection. 4) Patients participating in other clinical trial. 5) Any condition that is unstable or could jeopardize the safety of the patient and its compliance in the study, in the investigator's judgment.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method